PHOENIX, March 8, 2022 /PRNewswire/ — Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a leading commercial-stage biotechnology company focused on a regenerative approach to immunotherapy, of urology, neurology and orthopedics, today announced that leaders of the Society will participate in the 34and Annual Roth Conference to be held March 13-15, 2022 in Dana Point, California. Management will be available for individual meetings throughout the conference.
To learn more about the conference and submit a registration request, please visit:
A copy of the company’s latest investor presentation, which will be used in one-on-one meetings, is available on Creative Medical Technology‘s IR website at: https://creativemedicaltechnology.investorroom.com/.
Creative Medical Technology Holdings, Inc. is a commercial-stage biotechnology company specializing in stem cell technology in the fields of immunotherapy, urology, neurology and orthopedics. For more information about the company, please visit www.creativemedicaltechnology.com.
About Roth Capital Partners
Roth Capital Partners, LLC (“Roth”) is a relationship-oriented investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, Roth provides capital raising, M&A advisory, analytical research, trading, market making and corporate access services. Based at Newport Beach, CaliforniaRoth is a private, employee-owned company with offices across the United States. For more information about Roth, please visit www.roth.com.
SOURCE Creative Medical Technology Holdings, Inc.